The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma

Published:2024-05-01 Issue: Volume: Page:
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Mao Xudong¹,Chen Xianjiong¹,Xu Zhehao¹,Ding Lifeng¹,Luo Wenqin¹,Lin Yudong¹,Wang Ruyue¹,Xia Liqun¹,Wang Mingchao¹,Li Gonghui¹

Affiliation:

1. Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China

Publisher

Impact Journals, LLC

Reference49 articles.

1. Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer.;Mamtani;Eur Urol,2019

2. Immune Checkpoint Blockade in Metastatic Urothelial Cancer.;Balar;J Clin Oncol,2017

3. Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World Practice.;Mamtani;Oncologist,2019

4. PD-1regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.;Kinoshita;Proc Natl Acad Sci U S A,2019

5. CD8T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer.;Cao;Oncogene,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP